1. AB1174 ORM2 and APOA2 serum levels can predict oa patient response to chondroitin sulfate/glucosamine hydrochloride: results from the moves study. (15th June 2017) Authors: Calamia, V; Camacho-Encina, M; González-Rodríguez, L; Fernández-Puente, P; Rego-Pérez, I; Herrero, M; Martínez, H; Ruiz-Romero, C; Blanco, FJ Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1466 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mitochondrial DNA haplogroups and serum levels of proteolytic enzymes in patients with osteoarthritis. Issue 4 (21st December 2010) Authors: Rego-Pérez, I; Fernández-Moreno, M; Deberg, M; Pértega, S; Fernández-López, C; Oreiro, N; Henrotin, Y; Blanco, F J Journal: Annals of the rheumatic diseases Issue: Volume 70:Issue 4(2011) Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis. Issue 5 (23rd November 2009) Authors: Rego-Pérez, I; Fernández-Moreno, M; Deberg, M; Pértega, S; Fenández-López, C; Oreiro, N; Henrotin, Y; Blanco, F J Journal: Annals of the rheumatic diseases Issue: Volume 69:Issue 5(2010) Page Start: 910 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗